3C
TDOC icon

361 Capital’s Teladoc Health TDOC Stock Holding History

361 Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,421
Closed -$44K – 156
2016
Q3 		$44K Sell
2,421
-3,869
-62% -$67.9K 0.4% 38
2016
Q2 		$101K Buy
+6,290
New +$73.4K 1.51% 7

Other funds holding TDOC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $2.7B AUM 22.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

361 Capital's TDOC Position: Q4 2016 in Review

361 Capital sold out of Teladoc Health (TDOC) in Q4 2016, closing a stake of 2,421 shares — an estimated $44K sold.

361 Capital first reported a position in TDOC in Q2 2016 and held it in 2 quarters. The position peaked at $101K in Q2 2016. 108 funds tracked by Wall St. Rank hold TDOC as of Q4 2016.

  • 361 Capital reported no remaining Teladoc Health position as of Q4 2016 after selling out during the quarter.
  • 361 Capital sold 2,421 Teladoc Health shares in Q4 2016, an estimated $44K.
  • 361 Capital first reported a position in Teladoc Health in Q2 2016 and held it in 2 quarters.
  • 361 Capital's Teladoc Health position peaked at $101K in Q2 2016.
  • 108 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2016.

Based on 361 Capital's 13F filing for Q4 2016, filed 14 Feb 2017.